Range of qualified sufferers: CDEC talked about the uncertainty in the quantity of clients with moderately serious to serious hemophilia B in Canada suitable for etranacogene dezaparvovec. Clinical industry experts consulted by CADTH indicated that some clients who are categorised as owning mild or reasonable condition can have a significant https://hemgenix37169.csublogs.com/43214856/the-best-side-of-hemgenix